Nabsys
Latest round
- Series E
Last raised
- Aug 2014
Total raised
- $80M
Investors
- 4
About Nabsys
Nabsys specializes in electronic genome mapping technology, providing advanced tools for genomic analysis.Founded in 2004 by Barrett Bready, Nabsys operates from its headquarters in Providence, US, focusing on advanced genomic analysis.Nabsys offers a sophisticated electronic genome mapping platform designed to provide comprehensive insights into the human genome. The company's core product, the OhmX Analyzer, serves as a benchtop solution for detecting structural variants (SVs) at the whole genome level, enabling researchers to access critical genomic data with high sensitivity and accuracy. Additionally, Nabsys has developed the Human Chromosome Explorer™ (HCE) in collaboration with Hitachi High Tech, which comprises a suite of secondary analytical software tools that facilitate genome assembly and SV identification tailored to specific research parameters. These products are primarily targeted at academic and clinical laboratories engaged in genomic research, particularly in the United States, Canada, Europe, and select regions in Asia.Nabsys generates revenue through its direct sales model, offering products such as the OhmX Analyzer and the Human Chromosome Explorer to laboratories engaged in genomic research. The transaction structure typically involves B2B partnerships with academic institutions, research facilities, and clinical laboratories, where customers purchase the analytical tools to perform high-resolution genomic analyses. Nabsys provides training and support alongside its products, creating an integrated service offering that enhances customer satisfaction and retention. Pricing plans are structured around the procurement of devices, software licenses, and potential service contracts, ensuring that clients receive comprehensive support tailored to their research needs. Nabsys is also targeting expansion into additional geographic markets, focusing on regions in Asia and Europe by 2025.
Who invested in Nabsys
4 investors across 6 rounds
See all investors in Nabsys
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Nabsys
Who invested in Nabsys?
Nabsys has 4 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nabsys raised?
Nabsys has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Nabsys last raise money?
Nabsys's most recent round on record is a Series E, in Aug 2014.
What does Nabsys do?
Nabsys specializes in electronic genome mapping technology, providing advanced tools for genomic analysis.
Where is Nabsys headquartered?
Nabsys is headquartered in Providence, US.
Which VCs invest in companies like Nabsys?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nabsys's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Nabsys? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.